|
MechanismBacterial DNA gyrase inhibitors [+1] |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.- |
First Approval Date01 Jan 1989 |
|
MechanismH1 receptor antagonists |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.CH |
First Approval Date03 May 1979 |
100 Clinical Results associated with Novartis Ophthalmics, Inc.
0 Patents (Medical) associated with Novartis Ophthalmics, Inc.
100 Deals associated with Novartis Ophthalmics, Inc.
100 Translational Medicine associated with Novartis Ophthalmics, Inc.